Saturday 17 October 2026
Export A’s income statement to Excel — free account
Agilent Technologies, Inc.
A Healthcare Diagnostics & Research
Agilent Technologies, Inc.’s revenue for fiscal 2025 (year ended October 2025) was $6.9 billion, up 6.73% from fiscal 2024. In the quarter to July 2026, revenue grew 8.06%, EPS grew 8.47%, free cash flow grew 69.5% and total debt rose 8.81%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years.
172.96
2.59
−1.48%
Follow A
| Jul '26 | Apr '26 | Jan '26 | Oct '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
7 | 7 | 5 | 5 |
+8 more TTM periods Free account |
| 20.97% | 21.33% | 19.95% | 20.62% | ||
| 11.00% | 11.21% | 10.43% | 10.61% | ||
ROIC |
11.07% | 11.62% | 11.10% | 11.55% | |
Return on Tangible Assets |
31.73% | 30.79% | 28.93% | 30.52% | |
Average Days of Receivables |
73.18 | 75.60 | 78.58 | 78.12 | |
Free Cash Flow per Share |
4.49 | 3.85 | 3.51 | 4.06 | |
Free Cash Flow |
1,267.00 | 1,087.00 | 993.00 | 1,152.00 | |
Capital Expenditures |
(342.00) | (365.00) | (403.00) | (407.00) | |
| Other line items | |||||
Cash ROIC |
9.92% | 9.07% | 8.48% | 9.95% | |
Accounts Receivable Turnover |
5.16 | 5.05 | 4.96 | 4.94 | |
Accounts Payable Turnover |
5.98 | 6.04 | 5.87 | 5.96 | |
Inventory Turnover |
3.19 | 3.29 | 3.28 | 3.31 | |
Average Days of Payables |
65.19 | 65.67 | 65.11 | 62.95 | |
Days of Inventory on Hand |
119.77 | 116.29 | 114.53 | 113.20 | |
Tax Rate |
(0.13) | (0.11) | (0.10) | (0.09) | |
Research and Development Expense of Revenue |
6.58% | 6.54% | 6.50% | 6.55% | |
Selling, General and Administrative Expense of Revenue |
25.01% | 24.70% | 25.12% | 24.60% | |
Share Based Compensation of Revenue |
1.78% | 1.81% | 1.83% | 1.84% | |
Interest Coverage |
15.46 | 14.81 | 13.36 | 13.21 | |
Operating CF/Net income |
1.12 | 1.03 | 1.08 | 1.20 | |
Depreciation/Fixed assets |
0.13 | 0.13 | 0.14 | 0.14 | |
Capex/Depreciation |
(1.26) | (1.32) | (1.42) | (1.41) | |
Revenue per Share |
26.14 | 25.65 | 24.96 | 24.46 | |
Operating CF per Share |
5.71 | 5.15 | 4.93 | 5.49 | |
Capex per Share |
(1.21) | (1.29) | (1.42) | (1.43) | |
Capex to Sales |
0.05 | 0.05 | 0.06 | 0.06 |
Columns are period end dates